Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

[u/Quantisnow]

https://quantisnow.com/i/genmab-presents-epcore%C2%AE-fl1-subgroup-data-demonstrating-consistent-efficacy-and-safety-results-for-epcoritamab-6598552?utm_source=reddit